Graphical abstract graphic file with name fx1.jpg [33]Open in a new tab Highlights * • Differentiation of uniparental human ESCs into granulosa-like cells (GLCs) * • Androgenetic ESCs differentiate more efficiently to GLCs than parthenogenetic ESCs * • GLC differentiation of androgenetic ESCs depends on the imprinted gene IGF2 * • Supplementation of IGF2 partly rescues GLC differentiation of parthenogenetic ESCs __________________________________________________________________ In this report, Keshet and colleagues explore the genomic imprinting effect on ovarian development by differentiating biparental, parthenogenetic, and androgenetic human pluripotent stem cells into granulosa-like cells. They show that parthenogenetic cells display a reduced differentiation capacity, due to lack of expression of the paternal gene IGF2. These findings unravel an important contribution of the paternal genome to ovarian development. Introduction Genomic imprinting is an epigenetic phenomenon in mammals, leading to a parent-of-origin dependent monoallelic expression of a group of genes that are required for proper embryonic development ([34]Barlow and Bartolomei, 2014; [35]Reik and Walter, 2001; [36]Tucci et al., 2019). Various genetic disorders arise from aberrations in parental imprinting, and disruption in the expression of imprinted genes plays important roles in many pathologies ([37]Peters, 2014). Dissecting the unique roles of the paternal vs. the maternal genome during development is extremely challenging due to the difficulty in uncoupling them. To this end, the use of uniparental embryos or embryonic stem cells (ESCs), which either have a strictly maternal (parthenogenetic or gynogenetic) or paternal (androgenetic) genome has contributed greatly to imprinting research. More than 3 decades ago, pivotal experiments in mice showed that uniparental embryos are not viable, thus implicating imprinting as the mammalian barrier against asexual reproduction ([38]McGrath and Solter, 1984; [39]Surani and Barton, 1983; [40]Surani et al., 1984). Interestingly, these experiments also showed that while gynogenetic embryos had compromised extra-embryonic lineages, androgenetic conceptuses showed a compromised development of the embryo proper ([41]McGrath and Solter, 1984; [42]Surani and Barton, 1983; [43]Surani et al., 1984). Subsequent experiments with chimeric embryos composed of biparental and uniparental cells demonstrated different tissue distribution between parthenogenetic and androgenetic cells ([44]Barton et al., 1991; [45]Fundele et al., 1989, [46]1990; [47]Mann et al., 1990; [48]Nagy et al., 1989; [49]Thomson and Solter, 1988). Together, these observations suggested that there is a non-equivalent contribution from the two parental genomes to the development of various tissues. In humans, it is not possible to study embryonic development of chimeric or uniparental embryos in vivo due to obvious ethical reasons. Nonetheless, modeling tissue development through differentiation of uniparental human pluripotent stem cells (hPSCs) to different cell types can be utilized as a powerful alternative ([50]Stelzer et al., 2011). We have recently derived several novel human androgenetic and parthenogenetic ESC (aESCs/pESCs) lines. A global comparison of the methylome and transcriptome between these two cell types enabled the identification of new imprinted genes both within and outside of known imprinted regions ([51]Sagi et al., 2019). The importance of maintaining proper expression of imprinted genes during embryogenesis throughout adulthood is by now highly appreciated. Imprinted genes are known to regulate both behavioral and physiological processes including growth and survival, metabolism, the circadian clock, and neuronal function ([52]Peters, 2014). Nevertheless, while these various functionalities occur in the soma, the involvement of imprinted genes during the formation of the germline, especially in humans, remains elusive. This question is important from both evolutionary and reproductive therapy points of view. To address this issue, it is important to study the development of the germ cells as well as the somatic gonadal cells, which guide their differentiation. Indeed, if balanced imprinting is required for gonadal development, it adds a deeper layer of understanding to the mammalian barrier in asexual reproduction. Granulosa cells serve as somatic supporting cells to oocytes in the ovary. During mammalian fetal development, differentiation of granulosa cells from the gonadal primordium establishes the first essential step of female sex determination ([53]Rotgers et al., 2018). Indeed, these cells are not only vital for ovarian development, but are essential for ovarian function in adults ([54]Richards and Pangas, 2010). Thus, we reasoned that granulosa cells can be used as an attractive model for studying the development of the gonad. To explore whether genes that are expressed exclusively from one of the two parental genomes are essential for ovarian development, we compared the ability of biparental ESCs (biESCs), aESCs, and pESCs to differentiate into granulosa-like cells (GLCs). Remarkably, we observe an enhanced differentiation potential of aESCs compared with pESCs into GLC fate. Further analysis led us to identify IGF2 as the top-most upregulated paternally expressed gene (PEG) during the differentiation. Indeed, while knocking out IGF2 in aESCs results in their reduced differentiation capacity into GLCs, supplementation of recombinant IGF2 to pESCs during the differentiation leads to a partial rescue in their differentiation efficiency. We thereby reveal an essential role for the paternal genome in the formation of a female gonad, which is at least partly explained by the PEG IGF2. Results Differentiation of biparental ESCs into GLCs To study the contribution of imprinted genes to the development of the human somatic reproductive tissue, we took advantage of a differentiation protocol, which enables the derivation of human GLCs from human ESCs ([55]Lan et al., 2013). This 12-day protocol starts with the formation of embryoid bodies (EBs), which are first guided into mesodermal fate and finally to GLCs, positive for the marker genes AMHR2, FSHR, CYP19A1, AMH, and FOXL2. Using this protocol, we differentiated biESCs into GLCs (biGLCs) ([56]Figure 1A). Around day 10 of differentiation, large, vesicle-containing cells migrated out from the attached EBs ([57]Figure 1B). On day 12 of differentiation, we sorted AMHR2^+ biGLCs using fluorescence-activated cell sorting (FACS) for RNA extraction and performed RNA sequencing (RNA-seq). In agreement with previous reports ([58]Lan et al., 2013), day-12 biGLCs showed a consistent upregulation of AMHR2, FSHR, AMH, and FOXL2 granulosa markers and a downregulation of pluripotency markers compared with undifferentiated biESCs ([59]Figures 1C and [60]S1A). We noticed that sorting biGLCs led to very low yields and high degradation levels of RNA, possibly due to increased sensitivity of the differentiated cells to the sorting process. We therefore examined whether we could capture the transcriptional changes that occur throughout the differentiation in unsorted biGLCs samples. In agreement with the sorted samples, RNA-seq analysis of unsorted biGLCs showed the same upregulation and downregulation trend of different granulosa markers and pluripotency markers, respectively, albeit in a milder manner ([61]Figures 1D and [62]S1B). To further characterize the differentiation of biGLCs, we performed a differential expression analysis (DEA), which showed a significant upregulation of 1,467 genes and a downregulation of 554 genes in unsorted biGLCs compared with undifferentiated cells ([63]Figure S1C and [64]Table S1). Indeed, when performing a gene set enrichment analysis (GSEA), one of the most enriched gene ontology (GO) terms was "urogenital system development," together with some mesodermal lineages, as expected from the GLC differentiation protocol ([65]Figure S1D). In further agreement, the "ovarian steroidogenesis" pathway was significantly upregulated when performing GSEA for Kyoto encyclopedia of genes and genomes (KEGG) categories, further supporting the efficiency of the differentiation ([66]Figure 1E). Recently, a detailed single-cell road map of human gonadal development during the first and second trimester was published ([67]Garcia-Alonso et al., 2022). The large number of cells analyzed in this study enabled the identification of different populations of granulosa cells along the granulosa cell differentiation trajectory. These populations included the first and second waves of pre-granulosa cells (preGC-I/preGC-II), together with follicular granulosa cells, which emerge from early/mid-8 postconceptional week (PCW), and 17 PCW, respectively. Using this published dataset, we searched for differentially expressed genes that separate between the granulosa lineage (both pre- and follicular granulosa cells) and other lineages in the dataset (germ cells and other somatic lineages). This comparison yielded 240 genes that we coin "fetal granulosa markers" ([68]Table S2). Indeed, when performing a GSEA analysis on our biGLCs, upregulation of fetal granulosa markers is significantly enriched during the differentiation from biESCs ([69]Figure S1E), strengthening the ability of GLC to model granulosa cells during development. Next, we also performed a DEA to distinguish between different populations of fetal granulosa cells. This analysis resulted in 96, 70, and 268 markers that separate between preGC-I, preGC-II, and follicular granulosa cells, respectively ([70]Table S2). To try to position the GLCs along the granulosa cell developmental timeline, we compared the average expression of the top 10 markers for each fetal granulosa cell population in biESCs vs. biGLCs ([71]Figures 1F and [72]S1F). Interestingly, while markers for every fetal granulosa cell type were upregulated in GLCs compared with the undifferentiated state, the upregulation for preGC-I markers was the strongest, suggesting that GLCs correspond mainly to the first wave of pre-granulosa cells that emerge at 8 PCW ([73]Figure 1F). This result aligns with the relatively short differentiation protocol used in this study. Nevertheless, it should be noted that this similarity is determined only by a transcriptome analysis, and additional assays will be needed to measure the exact similarity of GLCs to in vivo preGLC-I. Together, these results suggest that biESCs can be efficiently differentiated into biGLCs, and that unsorted samples still capture the main transcriptional changes that occur during the differentiation process. We therefore continued the rest of the analysis using unsorted GLC samples. Figure 1. [74]Figure 1 [75]Open in a new tab Differentiation of biparental hESCs into GLCs leads to upregulation of granulosa specific markers (A) General scheme of GLCs differentiation protocol. (B) Microscopic images of day-10 GLCs. Scale bars, 50 μm. (C) Expression levels of different granulosa markers of sorted biparental GLCs (independent duplicates) vs. undifferentiated cells (independent triplicates [[76]Sagi et al., 2019], see [77]experimental procedures under “[78]external RNA-seq samples”). Bars represent mean ± SEM. (D) Expression levels of different granulosa markers of unsorted biparental GLCs (independent triplicates) vs. undifferentiated cells (independent duplicates). Bars represent mean ± SEM. (E) GSEA plots for GO categories that are enriched during differentiation to biparental GLCs and are likely relevant for granulosa cells. (F) Average expression (logCPM) levels of the 10 top-markers for different fetal granulosa cell types in unsorted biGLC vs. biESC cells. Bars represent mean ± SEM. Biased differentiation of uniparental ESCs into GLCs To check whether differentiation of ESCs into GLCs is dependent on genes that are expressed exclusively from the paternal or maternal genome, we differentiated parthenogenetic or androgenetic ESCs into GLCs (pGLCs/aGLCs, respectively, three different cell lines each). RNA was isolated from each cell type and the transcriptome of biGLCs was compared to that of pGLCs and aGLCs ([79]Figure 2A and [80]experimental procedures). First, we focused on the 1,467 genes that were significantly upregulated during the differentiation of ESCs into biGLCs (referred to as "granulosa-associated genes"). The change in gene expression in the differentiation into biGLCs was then compared with the changes in gene expression from pESCs into pGLCs and from aESCs into aGLCs. Strikingly, while aGLCs upregulated granulosa-associated genes in similar levels to that of biGLCs, pGLCs failed to do so for most genes ([81]Figure 2B). We then performed a GO/KEGG pathways overrepresentation analysis for granulosa-associated genes, which were upregulated (logFC >1) during aGLCs differentiation compared with pGLCs differentiation (see [82]experimental procedures and [83]Table S3). The five top GO terms and KEGG pathways for these genes included "urogenital system development," "ovarian steroidogenesis," and "cholesterol metabolism," with "urogenital system development" being the top overrepresented GO term ([84]Figure 2C). Indeed, "reproductive system development" term was also significantly overrepresented, despite not being part of the top five categories ([85]Figure 2C). We also compared the expression changes of granulosa markers that showed consistent upregulation during differentiation of sorted and unsorted biGLCs (i.e., AMHR2 and FSHR) between biGLCs and aGLCs/pGLCs differentiation. Interestingly, this comparison showed that while aGLCs upregulated the granulosa marker AMHR2 at a higher level than biGLCs, pGLCs upregulated AMHR2 to a lower extent ([86]Figure 2D). Indeed, an initial FACS experiment performed with an antibody against AMHR2 showed a stronger signal in aGLCs compared with pGLCs ([87]Figure S2A). This staining was not optimal, however, enabling the identification of a subtle qualitative trend, rather than a quantitative result. This trend was also true for FSHR, albeit pGLCs had a negligible disadvantage in upregulating FSHR compared with biGLCs, suggesting that FSHR upregulation might be enhanced by some paternal genes but is not dependent on them ([88]Figure 2D). Together, these results suggest that the paternal genome has a greater contribution compared with the maternal one for GLC differentiation. Figure 2. [89]Figure 2 [90]Open in a new tab Androgenetic hESCs differentiate more efficiently to GLCs than parthenogenetic hESCs (A) Schematic diagram of the different cell types used for GLCs differentiation. (B) Comparison of androgenetic or parthenogenetic differentiation with biparental differentiation (aESC: independent duplicates; aGLCs: independent triplicates; pESCs: independent duplicates; pGLCs: independent triplicates), focusing only on genes that are upregulated during biparental differentiation into GLCs. p = 2.0e-27 by Mann-Whitney U test. (C) Overrepresentation analysis for genes that are upregulated during biparental differentiation and are also upregulated during androgenetic differentiation compared with parthenogenetic differentiation (with logFC >1). (D) Comparison between expression changes of granulosa cell markers during androgenetic/parthenogenetic differentiation compared with biparental differentiation. IGF2 is the most upregulated imprinted gene during GLC differentiation Considering the advantage of aESCs to differentiate toward GLC fate, we analyzed the expression dynamics of imprinted genes during biGLC differentiation in search for candidates that might stand behind the bias. Interestingly, this analysis showed that the most upregulated imprinted gene during GLC differentiation is the PEG IGF2 ([91]Figure 3A). In support of this observation, re-examination of the developing human ovary small-cell RNA-seq (scRNA-seq) from [92]Garcia-Alonso et al. (2022) showed that IGF2 is widely expressed in the developing ovarian somatic tissue ([93]Figure S2B). Specifically, in the granulosa lineage, IGF2 highest expression is observed in preGC-I (the cells to which GLCs seem to resemble the most). During the second wave of pre-granulosa cells, IGF2 levels seem to diminish and are elevated in follicular granulosa cells ([94]Figure S2B). This observation opens the possibility that IGF2 might serve as a paracrine as well as an autocrine factor during granulosa cell development. As expected, a comparison between the expression changes of imprinted genes that occur upon aGLC vs. pGLC differentiation showed that IGF2 is much more upregulated during aGLC differentiation ([95]Figures 3B and [96]S2C). To further confirm the imprinting status of IGF2 in our uniparental cell lines, we also analyzed an Infinium HumanMethylation450 BeadChips dataset ([97]Sagi et al., 2019) and calculated the H19/IGF2 imprinting control region (ICR) methylation levels in aESC and pESC ESC lines. As reference, we also included three sperm samples and biparental ESC lines ([98]Figures S2D and S2E and [99]experimental procedures). While the sperm samples presented hyper-methylation and the biparental cell lines showed ∼50% methylation levels, our aESC and pESC lines showed hyper- and hypo-methylation levels, respectively, along the H19 ICR ([100]Figures S2D and S2E). In addition, we examined the methylation status of KvDMR1, a maternally methylated differentially methylated region (that should therefore be hypomethylated on the paternal allele), which like the H19 ICR, sits in the Beckwith-Wiedemann syndrome imprinted region on chromosome 11. As expected, KvDMR1 presented a mirror phenotype compared with the H19 ICR, with aESC and pESC lines showing hypo- and hyper-methylation levels, respectively ([101]Figures S2D and S2E). These results suggest that the uniparental cell lines maintain their parent-of-origin imprinting signature in the H19/IGF2 imprinted region. We therefore chose to focus on the role of the imprinted gene IGF2 during differentiation of ESCs into GLCs. Insulin-like growth factor 2 (IGF2) is a member of the insulin/insulin-like growth factors (IGFs) system, which also includes insulin and insulin-like growth factor 1 (IGF1). IGFs and insulin exert their physiological effects by binding and activating two tyrosine kinase receptors, namely the type-1 insulin-like growth factor receptor (IGF1R) and the insulin receptor (INSR) ([102]Gallagher and LeRoith, 2010). While IGF2 can activate both the INSR and IGF1R, insulin can only activate the INSR ([103]Neirijnck et al., 2019). We thus hypothesized that IGF2 may mediate IGF1R signaling during GLCs differentiation. In agreement with this hypothesis, IGF2 showed much higher expression levels compared with IGF1 in biGLCs ([104]Figure 3C). Moreover, both INSR and IGF1R were highly expressed in biGLCs, with IGF1R showing the higher expression between the two ([105]Figure 3C). This observation makes sense considering that IGF2, and not IGF1, is known to be the main IGF1R signaling mediator in the human ovary ([106]El-Roeiy et al., 1993). In agreement with IGF2 being the only imprinted IGF family member, neither IGF1, IGF1R, nor INSR showed any notable differences in expression among androgenetic, parthenogenetic, or biparental GLCs ([107]Figure S2F). These results, combined with the fact that the differentiation media, which is supplemented with serum replacement, contains insulin but not IGFs, suggest that IGF2 acts as the main IGF in GLCs and could potentially mediate IGF1R signaling in these cells. Figure 3. [108]Figure 3 [109]Open in a new tab Different imprinted genes are upregulated during GLCs differentiation (A) Volcano plot representation for imprinted (colored) and unimprinted (gray) gene expression changes during biparental GLCs differentiation. (B) Volcano plot representation for imprinted (colored) and unimprinted (gray) gene expression changes during androgenetic vs. parthenogenetic differentiation. (C) Expression levels of IGF2/IGF1 and INSR/IGF1R in biparental granulosa cells. Bars represent the mean ± SEM. The paternally imprinted IGF2 is essential for efficient GLC differentiation To explore whether IGF2 expression contributes to the higher propensity of aESCs to differentiate toward GLCs, we differentiated an aESC line harboring a knockout (KO) mutation for IGF2 (termed aESC/aGLCs^IGF2_KO), which we previously generated using CRISPR-Cas9 in combination with a single-guide RNA (sgRNA) targeting a constitutively expressed exon ([110]Sagi et al., 2019). Strikingly, RNA-seq analysis of aGLCs^IGF2_KO showed that they failed to upregulate most of the granulosa-associated genes compared with aGLCs ([111]Figure 4A). Interestingly, GSEA for GO terms and KEGG pathways that were associated with biGLCs and were also enriched during differentiation of aGLCs compared with pGLCs, showed that these categories were significantly depleted in aGLCs^IGF2_KO compared with aGLCs ([112]Figure 4B). Indeed, when comparing the full transcriptome of aGLCs^IGF2_KO with GLCs from different parental backgrounds, KO of IGF2 has a profound effect on the differentiation into GLCs ([113]Figure S3A). These results suggest that IGF2 strongly contributes to the advantage of aESCs, compared with pESCs, in differentiating toward GLCs. We also analyzed the expression levels of AMHR2, which was upregulated in higher levels during aGLCs and downregulated during pGLCs differentiation compared with biGLCs differentiation. This analysis showed a downregulation of the granulosa marker AMHR2 in aGLCs^IGF2_KO compared with aGLCs ([114]Figure 4C). Together, these results demonstrate an overall reduction in the efficiency of GLCs differentiation in the absence of IGF2, suggesting an essential role for IGF2 during the development of granulosa cells. Because IGF2 works in a paracrine/autocrine manner, a fascinating question is whether pGLCs differentiation could be enhanced if performed in the presence of exogenous IGF2. To explore this possibility, we supplemented pESCs with recombinant IGF2 throughout the differentiation protocol (termed pGLCs^+IGF2). Indeed, RNA-seq analysis of pGLCs^+IGF2 showed a significant enrichment of the most depleted categories in aGLCs^IGF2_KO, i.e., "reproductive system development" and "urogenital system development" categories, and an upregulation of AMHR2 in pGLCs^+IGF2 compared with pGLCs, essentially mirroring the results observed in aGLCs^IGF2_KO ([115]Figures 4D and 4E). To conclude, we observed an increased contribution of the paternal genome toward differentiation into GLCs, which could partly be linked to the PEG IGF2. Figure 4. [116]Figure 4 [117]Open in a new tab IGF2 is essential for GLC differentiation (A) Expression levels of genes upregulated during biGLCs differentiation in aESCs, aGLCs, or aGLCs^IGF2_KO (aGLCs^IGF2_KO: independent duplicates). (B) Relevant categories from GSEA based on aGLCs^IGF2_KO vs. WT aGLCs differential expression analysis. Dashed line represents significance threshold (p < 0.05). (C) Expression levels of AMHR2 for aGLCs^IGF2_KO vs. WT aGLCs. Bars represent mean ± SEM. (D) Relevant categories from GSEA based on pGLCs^+IGF2 (independent duplicates) vs. pGLCs (independent duplicates) differential expression analysis. Dashed line represents significance threshold (p < 0.05). (E) Expression levels of AMHR2 for pGLCs^+IGF2 vs. pGLCs. Bars represent mean ± SEM. NES, normalized enrichment score. Next, we searched for candidate TFs, which potentially mediate IGF2 contribution during GLCs differentiation. To this end, we performed an overrepresentation analysis of TF binding sites for the promotors of granulosa-associated genes that are more upregulated during aGLCs compared with pGLCs differentiation and are also upregulated (logFC >1) in aGLCs compared with aGLCs^IGF2_KO ([118]Table S4). This analysis identified six TFs, namely IGLV5-37, TCF7, GREB1, HES2, ZNF596, and ZNF92, that potentially regulate these genes ([119]Figures S3B and S3C). Interestingly, one of the most enriched TF binding sites was for GREB1, which is a chromatin-bound estrogen receptor (ER) coactivator that is essential for ER-mediated transcription ([120]Mohammed et al., 2013). Indeed, examination of the expression levels for the six TFs in different tissues as obtained from the GTEx database showed that GREB1 is highly enriched in the ovary compared with other tissues ([121]Figure S3D). This observation is even strengthened, considering that when looking on the scRNA-seq dataset from [122]Garcia-Alonso et al. (2022), GREB1 expression seems to be almost exclusively expressed in pre-granulosa and granulosa cells ([123]Figure S3E). These results possibly link between IGF2 signaling and GREB1-mediated transcription activation during granulosa cells development. Discussion Understanding the unique contribution of each parental genome to the development and maintenance of the various tissues in the human body is of great importance for basic research as well as for the better understanding of the genetic disorders that are associated with aberrations in imprinting ([124]Peters, 2014). Imprinted genes have been extensively studied in various physiological and behavioral contexts. Nonetheless, whether the requirement of sexual reproduction in mammals, which is mediated by imprinted genes, extends to the formation of the sex organs remained unknown. In this work we have differentiated ESC lines from different parental backgrounds into GLCs and compared their differentiation capacity through their transcriptome. We show that upon differentiation, biGLCs upregulate granulosa markers and activate genetic programs that are associated with reproductive system development and ovarian steroid production. Strikingly, while aESCs differentiate to GLCs with similar efficiencies compared with biESCs ([125]Figure 2B), pESCs fail to upregulate most of the granulosa-associated genes to the same levels as biGLCs. Moreover, we show that the granulosa-associated genes that are upregulated more in aGLCs than pGLCs differentiation, are highly enriched in terms that are specific to ovarian development and steroidogenesis. This finding is especially interesting considering that previous studies have shown that parthenogenetic cells, but not androgenetic cells, are able to contribute to the germline in chimeric mice ([126]Fundele et al., 1990; [127]Nagy et al., 1989). More recently, these observations were strengthened by a report of a successful differentiation of parthenogenetic ESCs into functional oocytes, which upon fertilization led to the birth of live and fertile mice ([128]Tian et al., 2021). Importantly, this does not mean that germ cell development in mice is not dependent on PEGs, as gonadal supporting somatic biparental cells in the chimeric mice and in the in vitro differentiation protocol (which depends on culturing the primordial germ cells with somatic ovarian cells taken from a wild-type (WT) fetal ovary) could still rely on PEGs. Imprinting is conserved between mice and humans, but most imprinted genes are not shared between them ([129]Tucci et al., 2019), and the function of some of the shared genes is not identical (as discussed below regarding IGF2). Thus, whether there is also a barrier for androgenetic cells to differentiate toward primordial and functional germ cells in humans, remains to be investigated. Nonetheless, if such a barrier exists, it may indicate that while a maternal genome is needed for oocyte differentiation, the paternal genome is needed for the development of the supporting somatic cells in the gonad, thus creating a requirement for both parental genomes in female gonadal development. In search of PEGs that could potentially contribute to the differentiation bias of the paternal genome, we identified IGF2 as the most upregulated PEG during GLCs differentiation. Importantly, we were able to show that aGLCs^IGF2_KO fail to upregulate most of the granulosa-associated genes and reproductive system development genes compared with WT aGLCs. Furthermore, addition of recombinant IGF2 throughout the differentiation of pESCs remarkably led to an upregulation of reproductive system development genes and the granulosa marker AMHR2 in pGLCs. The findings regarding IGF2 are intriguing considering that the insulin/IGF system is known to play important roles in gonadal function ([130]Neirijnck et al., 2019). Specifically, mice carrying a targeted disruption of the igf1r in granulosa cells are sterile, present small ovaries, and are devoid of antral follicles ([131]Baumgarten et al., 2017). Of note, granulosa IGF1R signaling in mice is likely mediated mainly by IGF1 and not IGF2, given that while igf1-null female mutants are infertile, paternally transmitted igf2 disruption leads to the birth of small but fertile mice ([132]Baker, 1996; [133]DeChiara et al., 1990). Moreover, IGF1 and not IGF2 is the primary IGF in the murine ovary ([134]Hernandez et al., 1989). In the human ovary, however, IGF2 is the primary IGF, and is most highly expressed by granulosa cells ([135]El-Roeiy et al., 1993). In the adult human ovary, IGF2 was shown to mediate the steroidogenic and growth-promoting actions of follicle-stimulating hormone (FSH) on pre-antral follicles during the menstrual cycle, through IGF1R-Akt signaling ([136]Baumgarten et al., 2014; [137]Yuan and Giudice, 1999). Specifically, FSH was shown to upregulate IGF2, which then synergizes with FSH to promote the proliferation and steroid production of granulosa cells in an Akt-dependent manner ([138]Baumgarten et al., 2015). However, while IGF2 has been strongly associated with the growth and differentiation of human adult follicles, whether it is essential for the initial development of granulosa cells, as modeled by our system, was previously unknown. Our findings thus add another layer to the known functions of IGF2 during human follicle maturation and highlight the importance of IGF2 already in the initial formation of granulosa cells. Interestingly, some patients with Beckwith-Wiedemann syndrome, which show biallelic expression of IGF2, were reported to suffer from ovarian hyperplasia, demonstrating the dosage sensitivity for IGF2 expression in the human ovary ([139]Mahat et al., 2019). Taken together, our results highlight the divergent roles of conserved imprinted genes such as IGF2 between mouse and human, considering that IGF1R signaling in the mouse ovary is primarily mediated by the non-imprinted gene igf1 and not igf2 ([140]Baker, 1996; [141]DeChiara et al., 1990). Moreover, we believe our findings should be taken into consideration when differentiating ESCs into GLCs, as IGF2 loss of imprinting is a known phenomenon that can happen when culturing ESCs ([142]Bar et al., 2017; [143]Keshet and Benvenisty, 2021), thus leading to a creation of a model that does not fully recapitulate its in vivo counterpart. Nevertheless, our study has some limitations. First, while the differentiation was strong enough to be captured in the transcriptome, it is important to keep in mind that because we did not sort the GLCs, the transcriptome is expected to represent some noise coming from a certain degree of differentiation heterogeneity in the samples. Moreover, despite the differences we observe between aGLCs and pGLCs, it is yet to be determined how these transcriptomic differences translate to the functionality of granulosa cells. Finally, the construction of reconstituted ovaries from somatic cells and germ cells that will all be differentiated from pESCs isolated from patient oocytes hold great promise for reproductive medicine. Our findings thus may be adopted in such future protocols to mitigate the lack of PEGs during GLCs differentiation, through addition of recombinant IGF2. Experimental procedures Resource availability Corresponding authors Further information and requests for resources and reagents should be directed to and will be fulfilled by the corresponding authors, Nissim Benvenisty ([144]nissimb@mail.huji.ac.il), Gal Keshet ([145]gal.cleitman@mail.huji.ac.il), and Talia-Eldar-Geva ([146]gevat@szmc.org.il) Materials availability This study did not generate new unique reagents. Cell lines Human ESC lines used in this study included three previously derived androgenetic cell lines (aES1, aES3, aES5) ([147]Sagi et al., 2019), three previously derived parthenogenetic cell lines (SWAPs4, pES6, pES10) ([148]Paull et al., 2013; [149]Sagi et al., 2016), and three previously derived biparental female lines (WA09, CSES7, CSES10) ([150]Thomson et al., 1998; [151]Lavon et al., 2008). For culture conditions and experiment repetitions see [152]supplemental experimental procedures. Differentiation of ESCs into GLCs Differentiation into GLCs fate was performed as previously described ([153]Lan et al., 2013) with slight modifications. See [154]supplemental experimental procedures. Flow cytometry For sorting of GLCs, differentiated GLCs were dissociated using TrypLE Select (Thermo Fisher Scientific) into single cells. The cells were then quenched with FACS buffer (10% FBS in PBS), centrifuged, and resuspended in FACS buffer containing mouse anti-human AMHR2 (1 μg per 10^6 cells, Abcam ab64762) antibody for 30 min on ice. Next, the cells were washed twice with FACS buffer followed by 30-min incubation with an Alexa Flour 488-conjugated Donkey anti-Mouse antibody (1:800, Abcam ab150109). The cells were then washed twice with FACS buffer. For each sort, a small number of GLCs were set aside and were only stained with the secondary antibody to serve as negative controls. At the end of each staining, cells were filtered through a 70-μm cell strainer and analyzed by flow cytometry (BD Biosciences FACSAria III) and FlowJo software (FlowJo LLC). For the flow cytometry experiment in [155]Figure S2A, differentiated GLCs were dissociated using TrypLE Select (Thermo Fisher Scientific) into single cells. The cells were then quenched with FACS buffer (10% FBS in PBS), centrifuged, and resuspended in FACS buffer containing rabbit anti-human AMHR2 cy3-conjugated antibody (4 μg per 10^6 cells, antibodies-online, ABIN1702944) for 30 min on ice. Next, the cells were washed twice with FACS buffer, resuspended in FACS buffer, filtered through a 70-μm cell strainer and analyzed by flow cytometry (BD Biosciences FACSAria III) and FlowJo software (FlowJo LLC). Generation and analysis of IGF2-knockout aESC lines The IGF2^KO aESC line (aES3) was previously obtained in the lab ([156]Sagi et al., 2019). For the IGF2^KO differentiation experiment, two independent replicates of aES3 IGF2^KO were used, and differentiation was performed using the same conditions as in other cell lines. RNA isolation and RNA-seq For high-throughput RNA-seq experiments, differentiated and undifferentiated cells were harvested at the end of differentiation assays. Total RNA was isolated using RNeasy Mini Kit (QIAGEN) and the mRNA fraction of total RNA was enriched by pulldown of poly(A)-RNA. RNA sequencing libraries were generated using TruSeq RNA Library Prep Kit (Illumina) according to the manufacturer’s protocol and sequenced using Illumina NextSeq 500 with 75 bp single end reads. For transcriptome analysis, reads were mapped to the GRCh38 reference genome using STAR ([157]Dobin et al., 2013). Because the hESCs samples were grown on mouse feeder cells, all the samples (including the GLC samples) were subjected to the XenofilteR software ([158]Kluin et al., 2018) with the MM_threshold paremeter set to 15 in order to remove reads originating from mouse contamination. Count table was created using featureCounts ([159]Liao et al., 2014). The sorted biGLCs library was un-stranded. The undifferentiated controls for the unsorted GLCs and all unsorted GLCs were prepared with minus stranded library preparation kit. External RNA-seq samples Because the sorted biGLCs library was un-stranded, three biESC samples that were prepared with an un-stranded library were downloaded from the SRA database to serve as controls for the sorted biGLCs ([160]Sagi et al., 2019) (accession number SRA: SRR7186863, SRR7186864, SRR7186853). The samples were of cell lines CU-ES4, CU-ES5, and NYSCF2. Differential expression analysis In RNA-seq experiments, EdgeR package in R v3.32.0 ([161]Robinson et al., 2010) was used for DEA, using trimmed mean of M-values (TMM) method for normalization and the generalized linear model approach for model testing ([162]Dunn and Smyth, 2018; [163]Robinson and Oshlack, 2010). For detailed description of the normalization, DEA model design and pathway enrichment analysis see [164]supplemental experimental procedures. Single-cell RNA-seq of fetal granulosa cells analysis To extract general and specific fetal granulosa cell markers, the single-cell dataset named "Human female" was downloaded ([165]www.reproductivecellatlas.org) and subsampled to 100K cells using scanpy library in Python ([166]https://scanpy.readthedocs.io/en/stable/) for further analysis. The dataset was then converted into a Seurat object and the rest of the analysis was performed with Seurat package V4.2.0 in R ([167]https://satijalab.org/seurat/; see [168]supplemental experimental procedures). Analysis of the methylation array Raw methylation data were downloaded from GEO under accession number GEO: [169]GSE114679 and analyzed using bioconductor’s minfi package (v.4.2). Genome browser style methylation representation was performed with bioconductor’s Gviz package (v.4.2). For detailed description of the analysis, see [170]supplemental experimental procedures. Statistical analysis Hierarchical clustering was performed using the pheatmap ([171]https://cran.r-project.org/web/packages/pheatmap/index.html). Scatterplots, boxplots, and bar plots were generated in R using the ggplot2 package ([172]Wickham, 2016). Author contributions G.K., S.B., N.B., and T.E.-G. conceived the study and designed the experiments. G.K. and O.Y. performed the experiments with a significant contribution from S.B. G.K. evaluated the data and performed the bioinformatic analysis. G.K. wrote the manuscript with input from S.B., R.S.-G., N.B., and T.E.-G. N.B. and T.E.-G. supervised the study. Acknowledgments